News

Bookmark and Share

This article is in the news archive.

New posts in Dementia and Neurodegeneration @KCL

The institute of Psychiatry, Psychology and Neuroscience are recruiting up to 10 researchers in Dementia and Neurodegeneration research at professor/senior lecturer/lecturer/fellows levels. For details, please see below and the weblinks to the job packs. The closing date is 31st of May. The contact person is Prof Chris Shaw: chris.shaw@kcl.ac.uk. Professor of Neurology and Neurogenetics, Head, Department of Basic and Clinical Neuroscience.

van Geest Professorship

The van Geest Professor of Dementia Research will be an exceptional clinical or non-clinical Neuroscientist who shares our ambition to make KCL one of the world’s leading centres for Dementia Research. Thanks to the generosity of the van Geest Foundation we are able to offer a highly competitive start-up package. Applicants whose work focuses on Alzheimer’s and/or Vascular Dementia are particularly encouraged but all aspects of Dementia are considered important.

The appointee will join thirteen Principal Investigators working on a wide range of Neurodegenerative disorders within the Department of Basic and Clinical Neuroscience. They will be based in the newly built Maurice Wohl Clinical Neuroscience Institute, which has excellent laboratories and access to cutting-edge equipment supporting: genetics, molecular and cellular biology, induced pluripotent stem cells, animal models of disease (drosophila, zebrafish and rodent), advanced microscopy (super-resolution, multiphoton in vivo, optogenetics, high content), rodent MRI, human PET and MRI imaging, neurophysiology and neuropathology.  For projects involving research and/or clinical trials on human patients we have access to a Clinical Research Facility. The Wohl works on the basis of equipment sharing and has many core facilities (sequencing, histology, microscopy) but we also have substantial funds available for additional specialist equipment. The support available for this post is unprecedented at the IoPPN.

We are a highly interactive group and are looking to recruit a scientist with a similarly collegial approach.  We work closely with colleagues in King’s College Hospital and South London and Maudsley NHS Foundation Trusts, with interests in the neurodegenerative disorders. We are keen to expand the scope of our collaborations with industry. Successful candidates will also have an opportunity to apply for funds through the £150m UK Dementia Research Institute

van Geest Fellowships

These Fellowships are funded by a donation to KCL from the van Geest Foundation and will provide salary for two years in the first instance and £50,000 start-up funds for consumables. All reasonable equipment costs will be covered by the department. These Fellowships are designed to support outstanding early career post-doctoral neuroscientists (3-7 years post PhD) who employ new technologies to answer important biological questions with translational impact across a wide range of neurodegenerative disorders. They are designed to help the researcher establish an independent and distinctive research niche, publish high-impact work and obtain further external Fellowship funding from a UK or EU Research Council, Charity or Industry.

The Fellows will join the Department of Basic and Clinical Neuroscience and be based in the newly built Maurice Wohl Clinical Neuroscience Institute. They will work independently but will be fully supported and mentored by our Principal Investigators. We encourage applicants who will benefit from the very wide range of technologies and resources available in the department including genetics, molecular and cellular biology, genome editing, patient-derived induced pluripotent stem cells, transgenic animal models of disease (drosophila, zebrafish and rodent), advanced microscopy, rodent MRI, human PET and MRI imaging and post-mortem patient material.  We particularly seek applications from scientists who take a novel approach to the study of neurodegeneration and have the talent and ambition to drive an innovative research programme. We are a strongly integrated and interactive group, and the post particularly suits a scientist who likes to collaborate within a strong collegial environment. 

Professor

The successful candidate will be an exceptional clinical or non-clinical Neuroscientist who shares our ambition to make KCL one of the worlds leading centres for research into Dementia and related Neurodegenerative disorders. We are able to offer a highly competitive start-up package to applicants whose research employs new technologies to answer important biological questions with translational impact across a wide range of neurodegenerative disorders.

The appointee will join thirteen Principal Investigators working on Neurodegenerative disorders within the Department of Basic and Clinical Neuroscience. They will be based in the newly built Maurice Wohl Clinical Neuroscience Institute, which has excellent laboratories and access to cutting-edge equipment supporting: genetics, molecular and cellular biology, induced pluripotent stem cells, animal models of disease (drosophila, zebrafish and rodent), advanced microscopy (super-resolution, multiphoton in vivo, optogenetics, high content), rodent MRI, human PET and MRI imaging, neurophysiology and neuropathology.  For projects involving research and/or clinical trials on human patients we have access to a Clinical Research Facility. The Wohl works on the basis of equipment sharing and has many core facilities (sequencing, histology, microscopy) but we also have substantial funds available for additional specialist equipment. The support available for this post is unprecedented at the IoPPN.

We are a highly interactive group and are looking to recruit a scientist with a similarly collegial approach.  We work closely with colleagues in King’s College Hospital and South London and Maudsley NHS Foundation Trusts, with interests in the neurodegenerative disorders. We are keen to expand the scope of our collaborations with industry. Successful candidates will also have an opportunity to apply for funds through the £150m UK Dementia Research Institute initiative.

Senior Lecturer

The successful candidate will be an exceptional clinical or non-clinical Neuroscientist who shares our ambition to make KCL one of the worlds leading centres for research into Dementia and related Neurodegenerative disorders. We are able to offer a highly competitive start-up package to applicants whose research employs new technologies to answer important biological questions with translational impact across a wide range of neurodegenerative disorders.

The appointee will join thirteen Principal Investigators working on Neurodegenerative disorders within the Department of Basic and Clinical Neuroscience. They will be based in the newly built Maurice Wohl Clinical Neuroscience Institute, which has excellent laboratories and access to cutting-edge equipment supporting: genetics, molecular and cellular biology, induced pluripotent stem cells, animal models of disease (drosophila, zebrafish and rodent), advanced microscopy (super-resolution, multiphoton in vivo, optogenetics, high content), rodent MRI, human PET and MRI imaging, neurophysiology and neuropathology.  For projects involving research and/or clinical trials on human patients we have access to a Clinical Research Facility. The Wohl works on the basis of equipment sharing and has many core facilities (sequencing, histology, microscopy) but we also have substantial funds available for additional specialist equipment. The support available for this post is unprecedented at the IoPPN.

We are a highly interactive group and are looking to recruit a scientist with a similarly collegial approach.  We work closely with colleagues in King’s College Hospital and South London and Maudsley NHS Foundation Trusts, with interests in the neurodegenerative disorders. We are keen to expand the scope of our collaborations with industry. Successful candidates will also have an opportunity to apply for funds through the £150m UK Dementia Research Institute initiative.

Lecturer

The successful candidate will be an exceptional clinical or non-clinical Neuroscientist who shares our ambition to make KCL one of the world’s leading centres for research into Dementia and related Neurodegenerative disorders. We are able to offer a highly competitive start-up package to applicants whose research employs new technologies to answer important biological questions with translational impact across a wide range of neurodegenerative disorders.

The appointee will join thirteen Principal Investigators working on Dementia and related Neurodegenerative disorders within the Department of Basic and Clinical Neuroscience. They will be based in the newly built Maurice Wohl Clinical Neuroscience Institute, which has excellent laboratories and access to cutting-edge equipment supporting: genetics, molecular and cellular biology, induced pluripotent stem cells, animal models of disease (drosophila, zebrafish and rodent), advanced microscopy (super-resolution, multi photon in vivo, optogenetics, high content), rodent MRI, human PET and MRI imaging, neurophysiology and neuropathology.  For projects involving research and/or clinical trials on human patients we have access to a Clinical Research Facility. The Wohl works on the basis of equipment sharing and has many core facilities (sequencing, histology, microscopy) but we also have substantial funds available for additional specialist equipment. The support available for this post is unprecedented at the IoPPN.

We are a highly interactive group and are looking to recruit a scientist with a similarly collegial approach.  We work closely with colleagues in King’s College Hospital and South London and Maudsley NHS Foundation Trusts, with interests in the neurodegenerative disorders. We are keen to expand the scope of our collaborations with industry. Successful candidates will also have an opportunity to apply for funds through the £150m UK Dementia Research Institute initiative.

https://www.mrc.ac.uk/news/browse/uk-s-first-dementia-research-institute-to-be-led-by-the-mrc/.

More information can be found here.

Posted on 23/05/2016

Further news

Go to the news index page.